Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05271240
Title Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Northwell Health
Indications

glioblastoma

IDH-wildtype anaplastic astrocytoma

Therapies

Bevacizumab + Temozolomide

Temozolomide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.